We focused on the cartilage differentiation and regulation by tissue-specific transcription factors during the period of this Grant-in-Aid for Scientific Research
本次科研资助期间我们重点关注组织特异性转录因子对软骨的分化和调控
基本信息
- 批准号:09671491
- 负责人:
- 金额:$ 1.92万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:1997
- 资助国家:日本
- 起止时间:1997 至 1998
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
1. cDNA screening for candidate gene of tissue-specific transcription factors of cartilageWe have screened rhondrocyte cDNA expression library by South-western technique to identify cDNA clones which can interact with enhancer elements of type II collagen gene. Four positive clones (CSEBP ; cartilage specific enhancer binding protein) were further analyzed for their mRNA expressioin pattern by Nothern blotting and/or RT-PCR analysis. These clones were expressed in cartilage ant other tissues such as brain and hears in mouse embryos. One of these clones were cDNA for type II collagen C-propeptide.2. Analysis of transgenic mouse overexpressing type II collagen C-propeptide.In order to educidate in vivo function of type II collagen C-propeptide which was isolated as a binding protein of type II collagen gene enhancer, we have generated transgenic mice harboritig cDNA for type II collagen C-propeptide with type II collagen promoter/enhancer to achieve high level expression of this construc … More t in cartilage tissue These mice showed mild dwarfism with shortening of long bone and delayed calcification. Immunohistochemical analysis and immuno-electron microscopy demonstrated the expression of this construct in the extracelular matrix of hypertrophic cartilage in growth plate and in rER in hypersrophic chondrocyte. Furthermore, these transgene molecule was detectable in nucleus of hypertrophic cartilage.Taken together with our previous in vitro study, these results indicate the possibility that type II collagen C-propeptide was taken up hypertrophic chondrocyte, translocated to nucleus and bound to the enhancer region of type II collagen gene enhancer to reduce transcription of this gene as a negative feedback regulator.3. Analysis of gene structure and production of knock-out mice of CSEBPTo analyze in vivo function of CSEBPs, we have screened mouse genomic library and constructed knock-out vector for one of these clones. CSEBP-2 has 14 exons expanding 8 Kb and this gene was expressed in ES cells. We have generated promoterless construct to generate knock-out mice for CSEBP-2. Less
1. 软骨组织特异性转录因子候选基因cDNA筛选采用西南技术筛选软骨细胞cDNA表达文库,筛选可与II型胶原基因增强子相互作用的cDNA克隆。通过northern blotting和/或RT-PCR分析四个阳性克隆(CSEBP;软骨特异性增强子结合蛋白)的mRNA表达模式。这些克隆在软骨和其他组织如小鼠胚胎的大脑和听觉中表达。其中一个克隆为II型胶原c -前肽2的cDNA。转基因小鼠过表达II型胶原c -前肽的分析。为了了解作为II型胶原基因增强子结合蛋白的II型胶原c -前肽在体内的功能,我们培育了含有II型胶原启动子/增强子的II型胶原c -前肽cDNA的转基因小鼠,实现了该结构的高水平表达。这些小鼠表现为轻度侏儒症,长骨缩短,钙化延迟。免疫组化分析和免疫电镜显示该结构在生长板增生性软骨细胞外基质和增生性软骨细胞内质网中表达。此外,这些转基因分子在肥大软骨细胞核中检测到。结合我们之前的体外研究,这些结果表明,II型胶原c -前肽可能被肥厚性软骨细胞吸收,易位到细胞核,并结合到II型胶原基因增强子的增强子区,作为负反馈调节因子减少该基因的转录。为了分析csebp在体内的功能,我们筛选了小鼠基因组文库,并构建了其中一个克隆的基因敲除载体。CSEBP-2有14个扩展8kb的外显子,该基因在胚胎干细胞中表达。我们构建了无启动子构建CSEBP-2基因敲除小鼠。少
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Matsui Y,et..al: "Splicing Patterns of type Xi collagen transcripts act as moleccular markers for osteochondrgenic tumors."Cancer Letters. 124. 143-148 (1998)
Matsui Y 等人:“Xi 型胶原蛋白转录本的剪接模式可作为骨软骨肿瘤的分子标记。”《癌症快报》。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Y.Fujita,et..al: "Novel mutations of the cathepsin K gene in patients with pycuodysostosis and their characterization [In Process Citation]"JClin Endocrino Metab. 85. 105-108 (2000)
Y.Fujita 等人:“脓性骨质疏松症患者组织蛋白酶 K 基因的新突变及其特征 [引用中]”JClin Endocrino Metab。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Sugimoto M,et..al: "Differential in situ expression of a2(XI) collagen mRNA isoforms in the developing mouse."Cell Tissue Res.. 292. 325-332 (1998)
Sugimoto M 等人:“发育中小鼠中 a2(XI) 胶原 mRNA 亚型的差异原位表达。”细胞组织研究 292. 325-332 (1998)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Matsui Y, Nakata K, Kimura T, Tsumaki N, Yamada Y, Kataoka B, Yasui N, Ochi T.: "Expression of the C-propeptide of type II collagen alters skeletal development in transgenic mice"Orthopaedic Transactions. 22. 669 (1999)
Matsui Y、Nakata K、Kimura T、Tsumaki N、Yamada Y、Kataoka B、Yasui N、Ochi T.:“II 型胶原蛋白 C 前肽的表达改变转基因小鼠的骨骼发育”《骨科汇刊》。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Matsui Y., Kimura T., Tsumaki N., Nakata K., Hashimoto N., Araki N., Ochi T.: "Expression of human a1 (XI) and a2 (XI) mRNA variants in cartilaginous tumors"Orthop Trans.. 21. 774 (1998)
Matsui Y.、Kimura T.、Tsumaki N.、Nakata K.、Hashimoto N.、Araki N.、Ochi T.:“软骨肿瘤中人 a1 (XI) 和 a2 (XI) mRNA 变体的表达”Orthop Trans。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
NAKATA Ken其他文献
NAKATA Ken的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('NAKATA Ken', 18)}}的其他基金
Mechano-signal transduction against 3-D mechanical stress in human connective tissue cells and MCS
针对人类结缔组织细胞和 MCS 中 3D 机械应力的机械信号转导
- 批准号:
23390363 - 财政年份:2011
- 资助金额:
$ 1.92万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Effects of mechanical stimulation on cells derived from synovial joint
机械刺激对滑膜关节来源细胞的影响
- 批准号:
19390395 - 财政年份:2007
- 资助金额:
$ 1.92万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
相似海外基金
The Role of CD96hi Cells Mediated by Transcription Factor Aryl Hydrocarbon Receptor (AHR) in HIV Pathogenesis.
转录因子芳基烃受体 (AHR) 介导的 CD96hi 细胞在 HIV 发病机制中的作用。
- 批准号:
502605 - 财政年份:2024
- 资助金额:
$ 1.92万 - 项目类别:
Collaborative Research: NSF/MCB-BSF: The effect of transcription factor binding on UV lesion accumulation
合作研究:NSF/MCB-BSF:转录因子结合对紫外线损伤积累的影响
- 批准号:
2324615 - 财政年份:2023
- 资助金额:
$ 1.92万 - 项目类别:
Standard Grant
Revolver Peptides - antagonising an "undruggable" transcription factor
Revolver 肽 - 拮抗“不可成药”的转录因子
- 批准号:
10073940 - 财政年份:2023
- 资助金额:
$ 1.92万 - 项目类别:
Grant for R&D
Rotation 1: Validation of a putative MYB transcription factor involved in chloroplast development
第 1 轮:验证参与叶绿体发育的推定 MYB 转录因子
- 批准号:
2887717 - 财政年份:2023
- 资助金额:
$ 1.92万 - 项目类别:
Studentship
Bivalent degraders of the understudied transcription factor TBXT for the rare cancer chordoma
正在研究的罕见癌症脊索瘤转录因子 TBXT 的二价降解剂
- 批准号:
10725821 - 财政年份:2023
- 资助金额:
$ 1.92万 - 项目类别:
The interface of transcription, DNA damage and epigenetics: A therapeutic vulnerability of the EWS-FLI1 transcription factor
转录、DNA 损伤和表观遗传学的界面:EWS-FLI1 转录因子的治疗脆弱性
- 批准号:
10718793 - 财政年份:2023
- 资助金额:
$ 1.92万 - 项目类别:
Activity-based regulome profiling for the discovery of covalent transcription factor inhibitors
基于活性的调节组分析用于发现共价转录因子抑制剂
- 批准号:
10603503 - 财政年份:2023
- 资助金额:
$ 1.92万 - 项目类别:
Targeting Kruppel-like Transcription Factor for White and Grey Matter Protection in Vascular Cognitive Impairment and Dementia
针对血管认知障碍和痴呆症中白质和灰质保护的 Kruppel 样转录因子
- 批准号:
10625096 - 财政年份:2023
- 资助金额:
$ 1.92万 - 项目类别:
Uncovering Nodal signaling and transcription factor interactions in somitic mesoderm development using single-cell deep learning methods
使用单细胞深度学习方法揭示体细胞中胚层发育中的节点信号传导和转录因子相互作用
- 批准号:
10749611 - 财政年份:2023
- 资助金额:
$ 1.92万 - 项目类别:
Elucidation of novel pathogenic pathways through comprehensive identification of regulatory genes for the autism transcription factor RFX
通过全面鉴定自闭症转录因子 RFX 的调控基因阐明新的致病途径
- 批准号:
23H02873 - 财政年份:2023
- 资助金额:
$ 1.92万 - 项目类别:
Grant-in-Aid for Scientific Research (B)